Is serum follicle-stimulating hormone level a predictor of bone mineral density in patients with hormone replacement therapy?
These data demonstrate that serum gonadotropin levels, especially FSH, are a good marker to predict BMD in women with HRT.
The effect of GnRH-A administration is affected by the presence of ovarian steroids.